In respect of TUEs granted, t he information reported shall include (in English or  French):  ISTUE – January 20 23 Page 14 of 23     a) Whether the Athlete was permitted to apply for a TUE retroactively under Article 4.1 and an explanation of the reason(s) why, or whether the Athlete was permitted to apply for and was granted a TUE retroactively  under  Article  4.3 and an explanation of the reason(s) why;  b) The approved substance or method, the dosage(s), frequency, route of Administration permitted,  the duration of the TUE (and,  if different,  the duration of prescribed treatment), and any conditions imposed in connection with the TUE ; and  c) The TUE application  form (if not completed electronically  in ADAMS) and the relevant  clinical information  establishing that the Article  4.2 conditions  have  been satisfied  in respect  of such  TUE (for access only by WADA , the Athlete’s National Anti -Doping Organization and International Federation, and the Major Event Organization organizing an Event in which the Athlete wishes to  compete).